Gracell Biotechnologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 16, 2022 at 07:30 am EDT
Gracell Biotechnologies Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was CNY 158.58 million compared to CNY 97.67 million a year ago. Basic loss per share from continuing operations was CNY 2.35 compared to CNY 1.65 a year ago. Diluted loss per share from continuing operations was CNY 2.35 compared to CNY 1.65 a year ago.